Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
2.
J Pharm Pract ; 35(5): 791-795, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-33779357

RESUMEN

PURPOSE: A case of loperamide-induced recurrent torsades de pointes is reported to raise awareness of an increasingly common phenomenon that could be encountered by medical providers during the current opioid epidemic. SUMMARY: A 40 year-old-man with a prior history of opioid abuse who presented to the emergency department after taking up to 100 tablets of loperamide 2 mg daily for 5 years to blunt opioid withdrawal symptoms and was subsequently admitted to the intensive care unit for altered mental status and hyperthermia. The patient had prolonged QTc and 2 episodes of torsades de pointes (TdP) that resulted in cardiac arrest with return of spontaneous circulation. He was managed with isoproterenol, overdrive pacing, and methylnatrexone with no other events of TdP or cardiac arrest. CONCLUSION: A 40-year-old male who developed torsades de pointes from loperamide overdose effectively treated with overdrive pacing, isoproterenol, and methylnatrexone.


Asunto(s)
Paro Cardíaco , Torsades de Pointes , Adulto , Analgésicos Opioides/efectos adversos , Proteínas de Unión al ADN , Electrocardiografía , Humanos , Isoproterenol/efectos adversos , Loperamida/efectos adversos , Masculino , Torsades de Pointes/inducido químicamente , Torsades de Pointes/diagnóstico , Torsades de Pointes/epidemiología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda